1765 participants
Phase 3b Trial To Evaluate Safety And Immune Response (Superiority) of a Two-Dose Butantan-DV Regimen And The Standard Single Dose In Dengue-Naive Children/Adolescents and Immune Response (Non-inferiority) in a Manufacturing Facility Change (DEN-06-IB)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-20
- Start Date:
- 2027-02-01
- Completion:
- 2028-02-28
Conditions
- Dengue Fever With Warning Signs
Interventions
- BIOLOGICAL
- OTHER
No Results Yet